Recent molecular classification of glioblastoma (GBM) has shown that patients having
Recent molecular classification of glioblastoma (GBM) has shown that patients having a mesenchymal (MES) gene expression signature exhibit poor overall survival and treatment resistance. model of glioma. Our studies reveal a 512-64-1 direct part for TAZ and TEAD in traveling the MES differentiation of malignant glioma. ((((= 385) to the previously explained Algorithm for the … [Read more…]